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The dose dependent effects of polyphenol supplementation on 
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Unaccustomed eccentric exercise can lead to decreases in muscle force production, 
increases in soreness, swelling, stiffness, and discomfort. The purpose of this study was 
to test the dose response of pomegranate juice concentrate on serum markers of muscle 
permeability, inflammation, and total anti-oxidant status. To test this hypothesis, 45 
healthy recreationally active males (22.3 ± 0.5 y, 73.8 ± 1.71 kg, 174.9 ± 0.9 cm) were 
recruited from the local Austin community for participation in this study. Subjects were 
disqualified from participation in the study if in the past 6 months they were engaged in 
an exercise training program. Subjects were placed into either the placebo group, the 
once-daily, or twice-daily pomegranate juice concentrate supplementation group. 
Subjects performed a total of 8 days of supplementation. On day 4, all subjects came to 
the laboratory and underwent an eccentric exercise protocol consisting of 2 minutes of 
downhill running at -10% grade at 7.5 mph repeated 10 times, resulting in ~20 minutes of 
total downhill running. Thereafter, subjects performed 50 eccentric elbow extensions 
 vi 
each lasting 5 seconds using a weight equal to their concentric one-repetition maximum. 
Blood measures were made pre-exercise (baseline), and 2, 24, 48, 72, and 96 hours post 
exercise and analyzed for interleukin-6, creatine kinase, myoglobin, and total anti-oxidant 
status. Creatine kinase was significantly elevated at 96 hours post exercise, but with no 
significant differences between treatments. Myoglobin was significantly elevated above 
baseline at 2 and 96 hours, but with no differences between treatments. There was no 
effect for time or treatment on the total anti-oxidant status of the serum. Il-6 was 
significantly higher at 2 and 24 hours after exercise, but with no difference between 
treatments. The percent increase in interleukin-6 from baseline was significantly lower in 
the twice-daily POM supplementation group versus placebo (124.3 ± 9.4, 188.6 ± 16.0% 
of baseline; respectively) during the 2-96 hours following eccentric exercise, but no 
statistical difference between 1x and 2x or 1x and placebo was observed. This suggests 
that 8 days of supplementation with pomegranate juice concentrate twice a day 
significantly reduces the percent increase in a marker of inflammation (interleukin-6) 
during the 96 hours following eccentric exercise; however, neither supplement was 
different than the placebo in regards to all other measures. 
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Unaccustomed eccentric exercise results in decreased muscle force production, 
increased soreness, and prolonged recovery lasting longer than 24-96 hours. The nature 
of eccentric exercise and the elongation while muscle contraction takes place results in 
very high force production across the muscle tissue. This results in sarcomeres that are 
non-uniformly stretched beyond their optimum length and longer sarcomeres may 
experience rapid and forceful stretching that results in them ‘popping’ and becoming 
damaged  [1]. This results in immediate strength loss due to mechanical damage and 
mediates an inflammatory process aimed at regeneration and repairing the muscle tissue.  
 The prolonged recovery could be a result of inflammation and oxidative stress 
following eccentric exercise [2-4]. Multiple studies have shown a relationship between 
muscle damage and inflammation and leukocyte infiltration suggesting a potential 
detrimental role of inflammation with eccentric exercise [5, 6]. The localization of 
immune cells can exacerbate damage to the muscle tissue due to macrophage 
phagocytosis generating free radicals, increasing oxidative stress, and aiding in muscle 
damage. It would therefore be advantageous to formulate interventions to attenuate this 
inflammatory response and possibly improve recovery following eccentric exercise. 
Previous studies examining polyphenol supplementation have shown an ergogenic 
effect with eccentric exercise [7-9]. These studies showed improved strength recovery 
with supplementation following eccentric exercise. Unfortunately, none of these studies 
were able to identify a mechanism resulting in improved recovery. It was however 
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suggested that attenuation of the inflammatory process could be a potential mechanism 
[7]. Of greater importance is the fact that none of the studies that use polyphenols to 
improve muscle function and recovery following eccentric exercise have tried to find an 
optimal dosage for supplementation [8-12]. Therefore, we propose to determine the 
effects of supplementation with pomegranate juice concentrate once or twice daily on 
markers of inflammation following eccentric exercise. We hypothesize that 
supplementation twice a day will result in lower measures of inflammation following 
eccentric exercise than once a day supplementation or placebo. Our second hypothesis is 
that once a day supplementation will result in lower measures of inflammation following 
eccentric exercise than the placebo. 
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REVIEW OF LITERATURE 
ECCENTRIC EXERCISE  
When muscle contracts concentrically it is activated and shortens while producing 
force. Alternatively, an eccentric contraction occurs when muscle is lengthened while 
producing very high force. When the volume and intensity of eccentric contractions 
becomes unfamiliar or novel it can be associated with muscle damage [13-15]. 
Individuals who are unaccustomed to eccentric muscle damage will experience the most 
dramatic losses in strength, increases in stiffness, swelling, soreness, and discomfort in 
the days following eccentric exercise [13-15]. The etiology of eccentric muscle damage 
lies in the contraction of the muscle as it elongates instead of shortens, which generates 
high levels of tension across the muscle tissue resulting in tissue damage.  This initial 
insult to the muscle causes immediate losses in strength, but also signals the localization 
of immune cells to remove and repair damaged tissue [14, 15]. This immune response 
helps to regenerate damaged tissue and may also be what causes the prolonged damage 
and delayed onset muscle soreness. It however has also been shown that this immune 
response may be beneficial for adaptation and confer protection against subsequent bouts 
of eccentric exercise. There have been attempts in the literature to attenuate the severity 
of the pro-inflammatory response and the delayed onset muscle soreness following 




 Delayed onset muscle soreness can occur after unaccustomed exercise with high 
force generation, more specifically, when the exercise is eccentric in nature. Delayed 
onset muscle soreness is a type of muscle strain that occurs and creates stiffness and 
swelling following muscle insult. Eccentric exercise is unique in that while the muscle is 
activated the muscle elongates rather than shortens. This mode of exercise typically 
results in higher tension across the muscle body. The higher tension with elongation is 
thought to lead to the weaker portions of the muscle being damaged, which can be seen 
immediately post exercise by histologically examining the streaming of the contractile 
units [13, 14, 16]. This streaming has been hypothesized to be due to the ‘popping’ of 
sarcomeres [17]. This theory states that during lengthening of the muscle, sarcomeres are 
non-uniformly stretched beyond their optimum length and longer sarcomeres may 
experience rapid and forceful stretching that result in them ‘popping’ and becoming 
damaged. The weak sarcomeres don’t appear uniformly in the muscle tissue, but result in 
focal lesions of damaged contractile units that stream and disrupt adjacent compartments 
such as the t-tubules. Studies that support this hypothesis show elongation of the muscle, 
which takes the sarcomeres out of their optimum length, results in more severe damage 
than when muscles are lengthened without taking sarcomeres out of their optimum length 
[18-20]. For example, Morgan et al. was able to show that the mere act of stepping down 
stairs two at a time with one leg while stepping down one at a time with the other leg 
resulted in subjects experiencing more pain and muscle damage with the leg that stepped 
down two stairs than the one that stepped down one stair at a time [1]. They suggested 
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that the nature of elongating the muscle by descending two steps at a time generates more 
weakened sarcomeres than when descending one stair at a time.  
 Disruption of the muscle tissue after mechanical stress results in an immediate 
loss in strength that can persist for several days [2, 21, 22]. This hallmark symptom of 
eccentric exercise is also considered to be one of the valid and reliable measures of 
muscle damage [23]. While soreness will peak 24-48 hours following eccentric exercise 
it is not a good reflection of muscle damage [2]. Concentric exercise can produce strength 
losses of 10-30%, but strength returns to baseline in the hours following exercise and is 
suggested to be due to fatigue rather than muscle damage [15, 24]. Alternatively, 
eccentric exercise can result in a 10-30% decrease in force production, with a recovery 
period of reduced strength lasting more than 96 hours [25-27], which is significantly 
longer than with concentric exercise [28]. The degree of strength loss is dependent upon 
the intensity of eccentric exercise and can reach as high as 50-65% loss in force 
production from baseline values [29, 30]. Different muscle groups may also experience 
different degrees of muscle damage. For example, downhill running protocols typically 
result in 20-30% decreases in leg strength [25, 31, 32], while maximal eccentric 
contractions of the elbow flexors have been reported to elicit a ~50% decrease in strength 
24 hours following eccentric exercise [29, 30]. 
 
SECONDARY INSULT 
 The high degree of damage following eccentric damage occurs due to mechanical 
strain tearing the microstructure of the muscle [33]. In response to damage the body starts 
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producing inflammatory markers called cytokines. Cytokines are biological markers that 
facilitate the attraction of immune cells and can be considered chemo-attractant 
molecules. Following eccentric exercise the pro-inflammatory response that ensues can 
increase the intracellular and plasma concentrations of TNF-α, IL-1β, and interleukin-6 
(IL-6), which signal for leukocyte infiltration. The accumulation of pro-inflammatory cell 
populations in the damaged tissue is likely to amplify the inflammatory injury to the 
muscle by the release of reactive oxygen species and with the activation of 
phospholipases and proteases in the tissue [34]. It is thought that the reactive oxygen 
species, phospholipases, and proteases facilitate the compromise of membrane 
permeability, calcium homeostasis, and can further degrade the muscle tissue following 
eccentric exercise [35]. 
 Localization of immune cells within the muscle occurs within the first 24 hours 
following eccentric exercise [3, 36, 37] and has been shown to persist for as many as 14 
days after eccentric exercise [38]. Neutrophils and macrophages exacerbate the muscle 
damage that occurs by generation of reactive oxygen species and nitrogen species [39, 
40]. As the immune cells phagocytose the damaged particles, they generate reactive 
oxygen species that can damage surrounding tissue. The degree of secondary damage and 
infiltration of leukocytes that occurs following eccentric exercise is dependent upon the 
muscle groups recruited and severity of muscle damage inflicted [41]. The role of 
inflammation in the etiology of delayed onset muscle soreness and recovery is debatable. 
Some studies show the acute phase response is associated with delayed onset muscle 
soreness and loss in force production following eccentric exercise [5, 6], but other studies 
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suggest a beneficial role of inflammation in adaptation [42-44]. Research in mice 
suggests an association between muscle hypertrophy and Il-6 providing a potential 
adaptive role of Il-6 in eccentric exercise [43, 45]. It is however unknown how recovery 
is effected by inflammation and if attenuation of inflammation would be beneficial to the 
recovery process. 
 The training adaptations from repeated eccentric exercise may begin as early as 
within the first 24 hours after eccentric exercise [46]. Koh et al. was able to show, in a 
very eloquent design that the protection conferred from eccentric exercise can be attained 
by passive stretching of the muscle tissue [42]. Mice underwent passive elongation of the 
extensor digitorium longus muscle without signs of muscle injury or regeneration. The 
mice that underwent passive stretching experienced only a 36% decrease in force 
following eccentric exercise while control mice experienced a 55% loss. Pizza et. al 
added to this finding, utilizing the same model, and showing leukocyte infiltration 
following passive elongation [44]. Passive stretching had a leukocyte response roughly 
half of the magnitude of the control mice after eccentric exercise. The passive elongation 
group also experienced a blunted inflammatory response and leukocyte infiltration after 
performing eccentric exercise. These two studies suggest that in the absence of muscle 
damage or repair there exists a mechanism facilitating adaptation against eccentric 
exercise. Pizza et. al were able to show an acute phase response that could suggest a role 
of inflammation and leukocytes in facilitating said adaptation. However no assessments 
of oxidative stress were made and the role of free radicals in this process is unknown. 
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Reactive oxygen species are generated because of oxygen’s diatomic nature. 
Oxygen found inside the body has two unpaired electrons in its outer shell, which can 
only be reduced one at a time resulting in the generation of free radicals [47]. Reactive 
oxygen species function by taking electrons from other molecules creating a new free 
radical in its place that results in a radical chain, which is typically terminated by reacting 
with an anti-oxidant [48].  
Reactive oxygen species are capable of reacting with all major types of 
biomolecules, but lipids are particularly prone to oxidation [49, 50]. The fact that lipids 
are prone to oxidation has been one of the reasons that many oxidative stress markers use 
oxidized lipids. The nature of reactive oxygen species and their attraction towards lipid 
oxidation results in membranes being attacked frequently [48]. Because of radical chains 
and since free radicals can move from one lipid to a neighboring lipid, muscle damage 
can occur at the site of origin or elsewhere quite easily [51]. The source of reactive 
oxygen species following eccentric exercise is likely from phagocytes rather than from 
the electron transport chain or xanthine oxidase found in endothelial cells. Generation of 
reactive oxygen species from the electron transport chain is associated with aerobic 
metabolism and is an unlikely source during eccentric exercise because of the low 
metabolic cost involved compared to concentric exercise [15]. A noteworthy point is that 
certain immune cells are able to generate large quantities of reactive oxygen species, 
namely monocytes/macrophages, eosinophils, and neutrophils [52].  
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REPEATED BOUT EFFECT 
Performing a single bout of eccentric exercise generates muscular adaptations that 
grant protection from further bouts of eccentric exercise. The degree of soreness and 
strength lost following each bout of eccentric exercise will be less severe than the 
previous bout [16, 25, 27, 53].  Adaptation to eccentric exercise has been shown to occur 
as early as within the first 24 hours following eccentric exercise [46]. Several other 
studies were able to show attenuations in creatine kinase (CK), soreness, and strength 
loss with repeated bouts of eccentric exercise [25, 46, 54]. Chen et al. was able to show 
that high intensity eccentric exercise provided greater protection than low intensity 
exercise with repeated bouts of eccentric exercise [55]. This would suggest a beneficial 
role for performing maximal eccentric contraction to maximize adaptations. However, 
Chen et al. showed in a later study that four low intensity bouts of eccentric exercise 
conferred as much protection as one bout of eccentric exercise at 100% of maximal 
voluntary contraction [56]. This could suggest more frequent less intense bouts of 
eccentric exercise could be less uncomfortable and still confer adequate protection. It 
might also suggest that screening of subjects needs to carefully take into account all 
forms of eccentric activity in daily living regardless of intensity before undergoing 
eccentric exercise. Rat studies have also shown that passive elongation of the muscle 
produces increases in interleukin-6 and infiltration of leukocytes, but also conferred 
protection against a subsequent bout of eccentric exercise in the absence of muscle 
damage or strength loss [42, 44]. This novel concept has even led to findings that suggest 
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undergoing static stretching or proprioceptive neuromuscular facilitation in humans 
attenuates the damage from a bout of eccentric exercise [57]. 
 
SUPPLEMENTATION 
 The effects of supplementation on eccentric exercise have led to controversy on 
their role to attenuate muscle damage and improve recovery [7, 9, 31, 58-66]. Previous 
studies have shown that anti-oxidant and anti-inflammatory supplementation can 
attenuate strength losses, inflammation, and muscle damage following eccentric exercise 
[7, 61, 65], but has also had equivocal findings as well [66-68]. This discrepancy in the 
literature is likely to stem from the supplement type.  
Vitamin C & E supplementation together or separatly has mostly shown no 
beneficial effect following eccentric exercise [63, 68-73]. Vitamin C supplementation 
was thought to mediate the oxidative stress following eccentric exercise, but many 
studies show no effect of vitamin C on muscle damage [66, 68, 74, 75]. Regardless of 
dose or duration there appears to be no positive effect of vitatmin C supplementation. 
Vitamin E was thought to be a potentially good supplement due to its fat soluble nature 
and would therefore stay in the body longer and possibly interact with cellular 
membranes. Vitamin E supplementation has led to equivocal findings as several studies 
show no effect on muscle damage [70, 76], with some showing a reduction in muscle 
damage only in the young compared to the elderly [77-79]. The combination of vitamin E 
& C results in similar findings as most studies show no effect of supplementation on 
muscle damage [80, 81]. 
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Interestingly, Phillips et al. was able to show the combination of vitamin E, 
omega-3 fatty acids, and flavanoids for 7 days was able to reduce markers of 
inflammation and oxidative stress 3 days after eccentric elbow flexion exercise [62]. In 
line with this literature, Taribian et al. showed lower TNF-α immediately, 24, and 48 
hours following eccentric exercise [58]. They were also able to show lower elevation of 
Il-6, CK, and myoglobin (Mb). These two studies might suggest a role of omega-3 fatty 
acids, which are a known anti-inflammatory. Furthermore, curcumin supplementation, a 
known anti-inflammatory, in mice has been shown to reduce inflammation and improve 
muscle function following downhill running [61]. These studies suggest a potential role 
for dietary anti-inflammatories in reducing inflammation and muscle damage following 
eccentric exercise. 
Polyphenols, such as ellagitannin, are commonly found in pomegranate juice and 
have anti-inflammatory and anti-oxidant properties. Polyphenols supplementation has led 
to positive findings and less equivocal responses following eccentric exercise [8, 9, 82]. 
Clinical applications for phenolics have also led to beneficial responses [83-85]. Tart 
cherry juice supplementation 4 days before and after an eccentric bout of exercise 
resulted in significantly higher strength at 24, 48, 72, and 96 hours post exercise 
compared to placebo [7]. Connolly et. al. suggested a potential role of reduced 
inflammation; however, these measures were not made.  In addition tart cherry juice has 
been shown to reduce pain after a long distance running race [12], and was able to reduce 
oxidative stress (TBARS), inflammation (IL-6), and aid in recovery following a marathon 
[11]. Pomegranate juice has also had equally positive findings showing improved 
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recovery of strength following eccentric exercise [8, 9]. Despite the number of studies 
that are able to show beneficial effects of polyphenols supplementation on strength 
recovery few studies are able to show attenuations in pro-inflammatory cytokines, CK, 
and Mb [58].  
 
CONTENTS OF POMEGRANATE JUICE 
 Polyphenols are typically found in the skin of brightly colored fruits or vegetables 
such as: tea, red wine, apples, pomegranates, cherries, coffee, blue berries, strawberries, 
and broccoli. Pomegranate juice has been shown to be beneficial by triggering apoptosis 
in cancer cells by modulating cell inflammatory processes [83]. It has also been shown to 
reduce the degree of reactive oxygen species released by macrophages [83, 84]. It has 
been suggested that compounds found in pomegranate juice work together synergistically 
granting it potent anti-oxidant capabilities [85]. In line with this finding, supplementation 
in mice has shown to be effective in reducing systemic oxidation of the liver [86]. 
Trombold et al. was able to show improved recovery of strength following eccentric 
exercise in two separate studies [8, 9], but was unable to elaborate on a mechanism as 
there was no effect on the blood measures of damage and inflamation [9]. Pomegranate 
juice is a potent anti-inflammatory and anti-oxidant due to the high concentrations of 
polyphenols, which include ellagitannins, ellagic acid, quercitine, kaempferol, and 
luteolin glycosides [87]. Of these the most prevalent is pinicalagin, an ellagitannin, which 




BLOOD MARKERS OF MUSCLE DAMAGE  
Blood markers of muscle damage are commonly measured with eccentric exercise 
and include: CK, Mb, lactate dehydrogenase, and myosin heavy-chain fragments. These 
markers however correlate poorly with muscle function and may not represent muscle 
damage per se [26, 89]. Furthermore, repeated bouts of eccentric exercise can result in an 
elimination of CK leakage into the blood while still experiencing disruption of the 
contractile units [27]. Creatine kinase measurements are based on activity not 
concentration and may not fully represent the flux of CK out of the damaged tissue. 
Creatine kinase has sulfhydryl (-SH) bonds, which are prone to oxidation and inactivation 
of the enzyme [90, 91]. It also is known that CK activity following eccentric exercise 
varies, likely due to oxidation and inactivation of the enzyme [91]. These findings 
suggest Mb as a better measure of damage with eccentric exercise, but it should be noted 
that CK and Mb are indices of membrane permeability and are poor reflections of  
muscle damage [23, 26, 89]. 
Inflammatory markers measured after eccentric exercise is typically in the form of 
cytokines, chemokines, or clinical markers like C-reactive protein [8, 61, 62, 92, 93]. The 
assessment of inflammatory markers can be done locally through muscle biopsies or 
isolation of muscle in animal models or systemically through blood markers. More 
studies assess inflammation with systemic measures because the invasive nature of a 
muscle biopsy has been shown to increase inflammatory markers and cause leukocyte 
infiltration in the absence of eccentric exercise [94]. 
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Oxidative stress is often measured by analyzing the oxidation of bimolecular 
markers after exercise. Typical markers are reduced glutathione, t-bars, plasma 
isoprostanes, or ferric reducing activity of plasma [95-98]. Additional measures are total 
anti-oxidant status of the blood, which assesses all endogenous and exogenous anti-
oxidants ability to reduce free radicals. This measure is more physiologically relevant as 






Forty-five healthy, non-smoking, males (22.3 ± 0.6 y, 73.8 ± 1.71 kg, 174.9 ± 0.92 cm) 
were recruited from the local Austin community for participation in this study. Subjects 
were disqualified from participation in the study if in the past 6 months they were 
engaged in an exercise training program or sustained an injury to the arms or legs, or 
participated in any physical therapy. Subjects were asked to refrain from the consumption 
of vitamin, mineral, anti-inflammatory or anti-oxidant supplements, and any over the 
counter medications throughout the duration of the testing period. Additional exclusion 
criteria was having a history of hypertension, active weight loss > 5 kg in the past 3 
months, and having any history of kidney dysfunction. They were also asked to 
discontinue any type of exercise outside of the study throughout the testing period. This 
study was conducted with the approval of the University of Texas Institutional Review 
Board, and each subject provided written consent. 
DESIGN 
This study was a double blind, counter balanced, placebo controlled experiment with an 
8-day supplementation period. Subjects took a one oz supplement of pomegranate juice 
concentrate or placebo, twice daily, approximately at 7 am and 7 pm. Subjects in the 
placebo group consumed placebo in the morning and the evening. Subjects in the 1x 
group took pomegranate juice concentrate in the morning and placebo in the evening, 
while the 2x group consumed pomegranate juice concentrate both in the morning and 
evening. On the morning of the 4th day of supplementation subjects performed a bout of 
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eccentric exercise used to elicit delayed onset muscle soreness. Subjects were assigned 
using a counter-balanced design into one of three groups: placebo (PLA), once-daily (1x), 
or twice-daily (2x) pomegranate juice supplementation.  
Blood samples were taken before supplementation on day 1 (pre), before eccentric 
exercise on day 4 (baseline), 2 hours, 24 hours, 48 hours, 72 hours, and 96 hours after the 
eccentric exercise. All blood draws were taken at the same time of day in the morning 
with subjects in a similar postprandial state. 
SUPPLEMENTATION 
Subjects took one ounce of placebo or pomegranate juice concentrate diluted with water 
to taste, which was taken at approximately 7 a.m. and 7 p.m. throughout the 8 day 
supplementation period. The 1x group took the pomegranate juice concentrate in the 
morning and placebo in the evening to ensure all groups still took supplements twice a 
day. The 2x group took pomegranate juice concentrate both in the morning and evening. 
The placebo group took a placebo both in the morning and the evening. All supplements 
were provided by POM Wonderful (Los Angeles, CA).  Each dose of pomegranate juice 
concentrate, one oz, contained 650 mg gallic acid equivalents (GAE) per dose. The 
pomegranate concentrate contained 62g of carbohydrate per 1 oz (total sugars: 49g, 
glucose: 25g, fructose: 24g), while the placebo contained 65g of carbohydrate per 1 oz 
(total sugars: 63g, glucose: 35g, fructose: 28g). The placebo was matched by color, 




Subjects performed an intermittent downhill running protocol, which consisted of 2 
minutes of downhill running at -10% grade at approximately 7.5 mph repeated 10 times 
and resulting in roughly 20 minutes of total running. This was performed by running 
down the ten story concrete ramps of the football stadium. Time between repetitions 
lasted roughly 2-4 minutes as subjects rode the elevator back up to the 11th floor. After 
completion of the downhill running portion of the eccentric exercise subjects performed 
50 eccentric elbow extensions (i.e.: preacher curls) each lasting 5 seconds using a weight 
equal to their concentric one-repetition maximum. The one-repetition maximum was 
determined by finding the highest weight the subject could lift once by continuing to add 
weight to a curling bar until the subject failed to complete a repetition. The subjects’ one-
repetition maximum was determined as the highest weight they could lift only once. 
Blood Collection 
Blood was collected from the anticubital vein and placed into serum separating tubes 
(Vacutainer, Franklin Lakes, NJ). The blood was left at room temperature for 45 minutes 
to coagulate, which was then centrifuged at 1500 G for 10 minutes at 4˚C and aliquoted 
into empty micro-centrifuge tubes. All samples were stored immediately at -80˚C. 
SERUM ANALYSIS 
Serum was analyzed for creatine kinase, myoglobin, total anti-oxidant status, and 
interleukin-6 using commercially available assays (Pointe Scientific, inc; Oxis 
International, Foster City, CA; Caymen Chemical, Ann Arobor, MI; Enzo Life Sciences, 
Farmingdale, NY). Samples were centrifuged at 17000 G for 5 minutes at 4˚C before 
 18 
analysis. The intra-assay and inter-assay reliability, as determined by the manufacturer,  
for creatine kinase was 0.65%, 0.75%; myoglobin was 5.44%, 8.25%; total anti-oxidant 
status was 3.4%, 3.0%;, and interleukin-6 was 5.3%, 6.5%; respectively. 
CREATINE KINASE 
Creatine kinase was measured in duplicate in the serum by measuring the enzyme 
kinetics of creatine kinase for converting ADP into ATP and eventually generating 
NAD+. Samples were measured by placing a small volume of sample, ~25 μl, into 1.0 mL 
of cocktail and watching appearance of NAD+ by reading at 340 nm on a 
spectrophotometer. By measuring the rate of appearance and utilizing the Beer-Lambert 
law creatine kinase was quantified. As this assay is dependent upon enzyme kinetics the 
values represent activity of creatine kinase in the serum rather than a concentration. 
MYOGLOBIN 
Myoglobin concentration was measured in duplicate in the serum using the enzyme-
linked immunosorbent method. Samples of serum were pippetted into antibody coated 
wells that bind Mb. A secondary antibody is added, which binds to the myoglobin, which 
contains an enzyme subunit generating a color change when the final photosensitive 
chemicals are added. The assay is measured using a spectrophotometer plate reader at 
450 nm. 
TOTAL ANTI-OXIDANT STATUS 
Total anti-oxidant status was measured in duplicate in the serum by utilizing a 
colorometric method whereby hydrogen peroxide oxidizes trolox resulting in a color 
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change. The assay measures all of the anti-oxidants in the sample by measuring how well 
the serum can prevent oxidation of trolox. Samples are quantified using a mM trolox 
equivalent standard as opposed to concentration of individual anti-oxidants in the serum. 
INTERLUEKIN-6 
Interluekin-6 was measured in duplicate using the enzyme-linked immunosorbent 
method. Samples of serum were pippetted into antibody coated wells that bind Mb. A 
secondary antibody is added, which binds to the myoglobin, which contains an enzyme 
subunit generating a color change when the final photosensitive chemicals are added. 
This assay was unique in that samples had a blank sample that was subtracted from each 
sample’s optical density. This step doesn’t occur in all assays and is typically added at the 
manufacturer’s discretion. This step occurs to help remove some of the back ground 
noise.  
STATISTICAL ANALYSIS 
Means and standard error were calculated for each of the descriptive statistics. A two-
way analysis of variance was used to compare creatine kinase, myoglobin, total anti-
oxidant status, and IL-6 between groups and across time. Significance was set at an alpha 
of 0.05. A Tukey’s post-hoc analysis was used when significance was reached. Statistics 





All three groups performed 10 repetitions of downhill running with -10% grade with no 
difference in speed (PLA: 7.73 ± 0.04, 1x: 7.61 ± 0.05, 2x: 7.64 ± 0.04 miles per hour; 
respectively) measured by knowing the distance traveled and the time it took to descend 
10 flights of ramps. Subjects performed 50 eccentric elbow extensions (i.e.: preacher 
curls) at their one-repetition maximum (PLA: 30.61 ± 1.97, 1x: 31.82 ± 2.13, 2x: 30.61 ± 
1.97 kilograms; respectively; p > 0.05) with no difference between groups in weight 
lowered (PLA: 1224 ± 97, 1x: 1139 ± 105, 2x: 1224 ± 97 kilograms; respectively). 
CREATINE KINASE 
There was a main effect of time (p < 0.01) for CK. A Tukey’s post-hoc test revealed that 
96 hours post exercise was significantly higher than baseline, 2, 24, 48 hours post 
exercise (1878 ± 744, 163 ± 19, 231 ± 18, 373.2 ± 30, 417 ± 112 U/L; respectively; p < 
0.04) (Figure 1).There was no difference between PLA, 1x, and 2x (476.2 ± 94.5, 567.2 ± 
163.0, 1001 ± 388.6 U/L; respectively) (Figure 2). Creatine kinase was significantly 
correlated with myoglobin (r = 0.63, p < 0.01) (Figure 3). Outliers were removed and 
creatine kinase was again significantly correlated with Mb (r = .195, p < 0.01) (Figure 4). 
Outliers were deemed as individuals that exhibited values ~4 times the group mean at any 
time point for either creatine kinase or myoglobin. 
MYOGLOBIN 
There was a main effect for time (p < 0.01) for myoglobin and Tukey’s post-hoc test 
revealed that 2 and 96 hours post exercise were significantly greater than baseline (148± 
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14, 152 ± 44, 22 ± 2 ng/mL; respectively; p < 0.03) (Figure 5). There was no difference 
between PLA, 1x, and 2x (68 ± 9, 94 ± 16, 121 ± 30 ng/mL; respectively) (Figure 6). 
TOTAL ANTI-OXIDANT STATUS 
There was no main effect for time (Pre: 1.50 ± 0.07; Baseline: 1.48 ± 0.07, 24: 1.62 ± 
0.06 mM Trolox equivalents; respectively; p > 0.05) (Figure 7). There was no main effect 
for treatment (PLA: 1.51 ± 0.07, 1x: 1.53 ± 0.07, 2x: 1.55 ± 0.07 mM Trolox equivalents; 
respectively) (Figure 8). 
INTERLUEKIN-6 
There was a main effect for time (p < 0.001). A Tukey’s post-hoc test revealed that 2 and 
24 hours post exercise were statistically higher than baseline, 48, 72, and 96 hours post 
exercise (5.40 ± 0.29, 5.20 ± 0.47, 2.87 ± 0.17, 2.80 ± 0.27, 3.18 ± 0.30, 2.89 ± 0.30 
pg/mL; respectively; p < 0.01) (Figure 9). There was no main effect between treatment 
groups (PLA: 3.72 ± 0.22, 1x: 3.90 ± 0.46, 2x: 3.82 ± 0.24 pg/mL; respectively; p > 0.05) 
(Figure 10). When the data was described as the percent increase in IL-6 over baseline 
there was a main effect for time (p < 0.001) and for treatment (P < 0.002). Tukey’s post-
hoc test revealed that 2 hours post exercise was significantly different from 0, 48, 72, and 
96 hours post exercise(228.15 ± 21.40, 100 ± 0.00, 106.16 ± 11.74, 131.58 ± 16.69, 
119.79 ± 15.84% higher than baseline; respectively; p < 0.002) (Figure 11). Tukey’s 
post-hoc analysis also revealed that 24 hours post exercise was significantly different 
from 0, 48, and 96 hours post exercise (195 ± 19.43, 100 ± 0.00, 106.16 ± 11.74, 119.79 
± 15.84% higher than baseline; respectively; p < 0.05) (Figure 11). Tukey’s post-hoc test 
revealed that the 2x group, as a treatment, was significantly lower than PLA (124.35 ± 
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9.46, 188.68 ± 16.01% of baseline; respectively; p < 0.001) during the 2-96 hour period 
(Figure 12).  
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Figure and Table Legends: 
Figure 1: Serum creatine kinase concentration vs. time. * Baseline (0), 2, 24, 48 hours 
post exercise were significantly lower than 96 hours post exercise (p < 0.04). 
Figure 2: Serum creatine kinase concentration vs. time with comparison between 
treatments. There was no difference between treatment groups. 
Figure 3: Serum creatine kinase concentration vs. serum myoglobin concentration and 
was significantly correlated (r = 0.63; p < 0.01). 
Figure 4: Serum creatine kinase concentration vs. serum myoglobin concentration, 
without outliers, was significantly correlated (r = .195, p < 0.01). Outliers were defined as 
individuals that exhibited values ~4 times the group mean at any time point for either 
creatine kinase or myoglobin and were removed from the above analysis. 
Figure 5: Serum myoglobin concentration vs. time. * 2 and 96 hours post exercise are 
significantly higher than baseline (0 h) (p < 0.03). 
Figure 6: Serum myoglobin concentration vs. time with comparison between treatments. 
There was no difference between treatment groups. 
Figure 7: Total anti-oxidant status vs. time. There was no difference across time. 
Figure 8: Total anti-oxidant status vs. time with comparison between treatments. There 
was no difference between treatment groups. 
Figure 9: Serum Interluekin-6 concentration expressed in picograms per milliliter 
(pg/mL). * 2 and 24 hours post exercise are significantly higher than baseline (0), 48, 72, 
and 96 hours post exercise (p < 0.01). 
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Figure 10: Serum Interluekin-6 concentration vs. time with comparison between 
treatments. There was no difference between treatment groups. 
Figure 11: Serum Interluekin-6 concentration expressed as a percentage of baseline (0). 
* 2 hours post exercise is significantly different from baseline (0), 48, 72, and 96 hours 
post exercise (p < 0.001). † 24 hours post exercise is significantly different from baseline 
(0), 48, and 96 hours post exercise (p < 0.01). 
Figure 12: Serum Interluekin-6 concentration expressed as a percentage of baseline. * 
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The major finding in this study is that pomegranate juice supplementation twice a 
day over eight days attenuated the relative rise of the inflammatory marker IL-6 in the 2-
96 h period following an eccentric bout of exercise compared to placebo. The present 
study suggests that eccentric muscle damage occurred and resulted in increases in CK, 
Mb, and IL-6. To our knowledge this is the first study to show attenuations in the rise of 
IL-6 compared to control with twice daily pomegranate juice supplementation following 
eccentric exercise. This supports our hypothesis that pomegranate juice supplementation 
might reduce inflammation following eccentric exercise. We were unable to show 
changes in total anti-oxidant status after exercise with or without supplementation. Other 
dietary interventions such as vitamin C & E supplementation have been unsuccessful at 
attenuating the biochemical measures (CK, Mb, and proinflammatory cytokines) after 
eccentric exercise [31, 63], which is thought to be due to the source or dose of the 
supplement. For example, most studies do not support the idea that vitamin 
supplementation reduces muscle damage [63, 68-72], while other non-vitamin anti-
inflammatory supplements show beneficial effects following eccentric exercise [7-9, 58, 
61]. 
This study was able to show attenuation in the relative increase in  IL-6, likely 
due to the use of phenolics in the pomegranate concentrate, which have been previously 
shown to improve strength recovery [7-9] and decreased soreness and pain [7, 9, 11, 12], 
following eccentric exercise. The findings in this study are similar to other studies 
utilizing omega-3 fatty acid supplements, which have been able to blunt increases in pro-
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inflammatory cytokines and markers of muscle damage after eccentric exercise [58, 62]. 
However our findings conflict with previous research on pomegranate juice concentrate, 
which showed no effect of supplementation to attenuate IL-6 following eccentric exercise 
[8]. The most immediate answer would be mode of eccentric exercise. Supplementation 
content was the same (as measured by gallic acid equivalent), but the current study 
incorporated a different eccentric protocol potentially recruiting more muscle because of 
the downhill running, allowing for the effects of supplementation to be apparent.  We 
propose that twice daily pomegranate juice supplementation could have a beneficial  
effect, by attenuating the increase in IL-6 during the 2-96 h period following eccentric 
exercise.  
There is a section of the literature that supports the positive role of IL-6 in 
adaptation to eccentric exercise [42, 44, 46], which would suggest supplementation to be 
detrimental. Thus, it is unknown whether a supplement that reduces IL-6 would impair or 
enhance muscle repair and adaption processes after eccentric exercise. While multiple 
studies do show an improvement in strength recovery with polyphenol supplementation 
[7-9], it has yet to be determined if supplementation alters the protection conferred due to 
eccentric exercise. 
The ellagitannins found in pomegranate juice have been described as the active 
constituent in pomegranate juice that would have facilitated changes in IL-6 [83]. In this 
study, pomegranate juice supplementation did not result in an increase in total anti-
oxidant status, but not all studies have found this effect [68].  Our results might be due to 
a lack of sensitivity in detecting any single anti-oxidant in the blood, especially since the 
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contributions of endogenous anti-oxidants are major contributor to total anti-oxidant 
status [10, 73]. Future studies should use more sensitive and specific measures of the 
anti-oxidant capabilities of pomegranate juice supplementation. 
We also were unable to show a decrease in the total anti-oxidant status of the 
serum after eccentric exercise using total anti-oxidant status. Even in studies using the 
ratio of reduced glutathione vs. oxidized glutathione, a very sensitive measure of the 
oxidative stress produced during exercise, were unable to show evidence of an oxidative 
stress response after eccentric exercise [98, 100]. The inconsistency or inability to detect  
oxidative stress after eccentric exercise is likely due to the degree of muscle damage 
induced, an inability to detect changes in muscle with plasma measures, or differences in 
the specific measurements [101]. Our inability to detect changes in total anti-oxidant 
status following eccentric damage is likely due to one of these factors, most significantly 
the assay type.  
Our data show increases in myoglobin and creatine kinase after exercise, which 
agrees with the current literature [31, 32, 102]. However, supplementation did not 
attenuate the rise in either of these intracellular proteins. While most studies show 
increases with creatine kinase and myoglobin it was very unusual to see such a delayed 
increase in creatine kinase and two peaks with myoglobin. The 96-hour post exercise 
peak in creatine kinase and myoglobin may be explained from the mode of exercise 
(eccentric elbow flexion) as similar protocols have shown peaks occurring at the same 
time [21, 55, 91]. Alternatively, the early rise in myoglobin might be explained from the 
downhill running as several studies have shown early peak values of myoglobin within 
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the first 24 hours following eccentric exercise [25, 31, 32]. This data might suggest that 
the odd and atypical response we show is due to the two modes of eccentric damage we 
used during our protocol. Furthermore, we speculated that pomegranate juice 
supplementation may not have a direct benefit to maintain muscle cell membrane 
permeability. Many other studies also have shown increases in intracellular proteins 
regardless of supplementation suggesting no effect of the treatment to attenuate muscle 
permeability [31, 62, 63]. It is therefore possible that the pomegranate juice provided 
beneficial effects by reducing inflammation without significantly improving muscle 
membrane permeability. 
Future studies should use more direct measures of muscle inflammation, muscle 
damage, and redox state by taking muscle biopsies. Without specific measures for muscle 
damage (i.e.: isometric strength), or soreness we are unable to elaborate on the potential 
ergogenic or ergolytic effects of the pomegranate juice supplementation. It should also be 
investigated if supplementation with pomegranate juice alters the protection inferred 
through repeated bouts of eccentric exercise, which could determine if the inflammation 
following eccentric exercise plays a role in adaptation. Future studies should elucidate 
what changes are occurring intracellularly to attenuate the systemic IL-6 response shown 
in the current study. 
In summary we found that pomegranate juice supplementation twice daily for 
eight days attenuated the relative rise in IL-6 during the 2-96 h period following eccentric 
muscle damage. We attribute this finding to the ellagitanins found in pomegranate juice, 
which are known to be anti-inflammatory and anti-oxidants. Future studies should focus 
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on uncovering the mechanism for attenuating IL-6 and the specific effects of IL-6 this 








 Creatine Kinase (CK) 
 Myoglobin (Mb) 
 Total-Anti-oxidant Status (TAS) 
 Interluekin-6 (IL-6) 
Interluekin-6 (Fold increase over baseline) 
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Creatine Kinase (U/L) 
Placebo 0 2 24 48 73 96 
1 62.79 126.07 170.56 160.34 151.28 457.46 
2 132.49 202.69 344.41 230.38 155.73 139.58 
5 92.45 139.58 198.41 120.30 92.12 124.09 
7 115.19 233.84 542.33 400.44 274.38 399.45 
12 98.05 158.86 459.11 185.06 137.44 125.24 
18 106.13 155.40 219.67 125.08 244.55 101.18 
21 239.61 358.26 766.77 811.60 3473.79 6580.10 
24 230.54 561.77 1024.51 844.72 3058.52 3819.03 
30 83.05 171.05 319.04 190.33 167.92 167.43 
33 156.39 212.58 233.01 226.26 210.27 631.81 
36 88.00 122.93 275.53 134.47 277.18 426.97 
39 160.67 269.10 339.14 213.57 234.83 223.95 
42 164.13 194.95 563.91 329.42 523.38 778.31 
45 119.80 239.44 153.09 121.78 197.91 1095.20 
50 932.06 825.44 490.25 399.29 374.90 869.93 
              
Mean 185.42 264.80 406.65 299.54 638.28 1062.65 
SEM 54.94 49.35 62.72 60.31 277.56 460.83 
       
1x 0 2 24 48 72 96 
3 134.30 156.06 285.75 306.84 145.35 214.23 
9 76.79 106.13 161.66 259.55 397.31 228.89 
11 206.32 242.74 224.28 150.95 116.01 111.56 
13 96.40 127.71 321.34 259.38 5619.37 12437.60 
17 62.13 148.15 97.06 81.08 94.43 86.84 
20 259.88 333.21 258.23 221.64 227.08 234.17 
26 38.07 141.89 336.67 247.68 199.56 179.46 
29 127.88 159.35 194.62 151.61 135.29 135.62 
32 205.82 292.17 541.50 305.03 1461.37 3228.09 
35 142.21 182.75 636.75 272.89 157.05 232.19 
38 181.76 166.27 333.70 214.56 168.58 159.35 
41 89.32 215.88 300.08 178.47 824.94 5710.83 
44 273.88 381.33 414.78 395.83 277.18 200.72 
48 66.91 222.96 488.77 348.86 247.19 876.36 
49 132.16 229.06 538.87 521.56 1597.32 1102.78 
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Mean 139.59 207.04 342.27 261.06 777.87 1675.91 
SEM 18.68 20.35 39.81 28.04 367.56 867.19 
       
2x 0 2 24 48 72 96 
4 71.02 168.58 459.44 237.79 134.63 135.13 
6 190.00 246.53 426.81 387.09 363.03 351.99 
8 224.45 235.98 281.63 298.11 220.33 172.04 
10 114.04 153.75 215.55 219.67 174.02 224.94 
14 155.40 221.48 333.37 195.61 134.63 388.08 
16 116.67 187.37 310.14 365.18 326.62 241.75 
19 202.36 298.27 347.87 256.41 268.28 277.34 
22 111.56 168.75 295.47 1173.64 4165.09 7197.25 
25 241.91 374.24 308.82 351.00 269.60 356.28 
28 126.07 205.33 444.44 5144.94 15844.65 30601.69 
31 181.60 180.12 225.43 148.81 198.90 185.88 
34 90.64 148.64 490.42 516.78 876.85 1503.22 
40 171.55 194.29 178.47 184.73 137.44 107.77 
43 166.11 240.43 193.63 159.52 143.37 111.07 
46 299.26 296.13 1050.71 724.09 1654.17 1617.42 
              
Mean 164.18 221.33 370.81 690.89 1660.77 2898.12 





Placebo 0 2 24 48 73 96 
1 10.28 176.76 40.88 20.83 26.11 140.89 
2 8.81 82.65 45.94 8.81 19.78 24.63 
5 32.86 116.41 58.81 70.21 44.04 24.00 
7 41.51 251.03 74.43 53.33 44.46 37.29 
12 13.85 260.52 40.93 40.93 6.57 26.66 
18 19.98 116.13 25.51 34.63 48.99 33.25 
21 29.10 140.72 60.60 87.40 372.24 484.97 
24 17.59 387.90 35.43 76.43 157.62 408.93 
30 19.72 211.40 26.11 41.82 53.80 93.47 
33 26.09 154.21 29.04 39.49 17.25 39.76 
36 10.00 30.65 30.77 16.83 25.29 60.94 
39 27.17 73.27 15.64 11.35 22.34 3.04 
42 3.63 196.52 22.50 29.77 22.70 34.39 
45 24.72 32.13 2.85 2.55 25.51 23.14 
50 37.08 105.45 21.04 23.41 33.14 57.33 
              
Mean 21.49 155.72 35.37 37.19 61.32 99.51 
SEM 2.85 24.70 4.85 6.57 24.01 37.62 
       
1x 0 2 24 48 73 96 
3 10.07 151.44 38.13 20.62 20.20 19.78 
9 23.75 45.01 31.61 96.85 35.69 30.74 
11 39.18 194.12 38.02 25.21 24.62 12.39 
13 26.08 171.40 35.78 138.86 715.25 626.90 
17 16.39 75.79 20.54 26.34 18.88 17.50 
20 62.81 138.23 50.65 33.80 71.93 63.08 
26 22.92 355.69 79.09 22.92 40.49 29.04 
29 16.00 82.55 29.84 33.04 16.00 12.00 
32 15.91 261.15 22.88 16.18 318.24 275.35 
35 9.48 227.11 62.81 22.07 18.59 13.50 
38 10.55 46.46 28.51 5.72 14.03 7.06 
41 11.31 94.43 13.46 21.62 227.27 969.51 
44 7.56 89.42 21.12 24.76 7.76 13.07 
48 32.08 406.27 48.12 56.01 115.18 220.62 
49 37.08 336.06 39.97 183.81 132.80 78.63 
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Mean 22.75 178.34 37.37 48.52 118.46 159.28 
SEM 3.88 30.08 4.47 13.21 48.56 72.05 
       
2x 0 2 24 48 73 96 
4 32.65 30.75 67.25 33.28 44.89 51.64 
6 13.66 114.73 29.06 28.01 35.39 23.36 
8 5.40 137.62 12.10 19.09 24.33 22.29 
10 22.00 143.15 42.97 14.72 10.35 30.74 
14 21.42 168.78 13.56 17.92 14.72 53.45 
16 29.65 90.71 43.47 34.07 46.51 30.48 
19 57.01 205.65 72.20 65.85 51.76 86.02 
22 39.05 48.72 75.75 402.86 1463.08 1559.85 
25 38.36 154.96 57.26 55.66 32.50 69.51 
28 24.52 233.76 142.98 1112.29 1339.11 690.13 
31 29.57 82.55 11.47 21.59 16.53 33.57 
34 13.23 51.29 58.26 41.91 101.68 254.45 
40 5.99 47.16 8.15 10.61 12.28 9.63 
43 30.77 37.24 5.40 11.10 30.24 10.02 
46 3.14 124.69 25.45 25.15 97.37 64.46 
              
Mean 24.43 111.45 44.36 126.27 221.38 199.31 




Total Anti-oxidant Status (mM trolox equivalents) 
Placebo Pre-Supp 0 24 
1 1.97 2.03 1.95 
2 1.94 2.06 1.96 
5 1.93 1.93 2.13 
7 1.81 1.96 1.83 
12 1.93 2.00 1.98 
18 1.78 2.09 1.96 
21 2.08 1.79 1.77 
24 1.69 1.53 1.54 
30 1.40 1.19 1.36 
33 0.97 1.16 1.23 
36 0.56 0.60 0.60 
39 1.88 1.17 1.32 
42 0.71 0.50 1.51 
45 1.11 1.59 0.60 
50 0.63 1.00 1.19 
        
Mean 1.49 1.51 1.53 
SEM 0.14 0.14 0.12 
    
1x Pre-Supp 0 24 
3 2.00 2.07 1.88 
9 1.86 1.98 1.67 
11 1.94 1.99 1.98 
13 1.99 2.00 1.96 
17 2.05 1.90 2.03 
20 2.11 1.97 2.01 
26 1.33 1.73 1.82 
29 1.61 1.64 1.90 
32 0.68 0.78 1.43 
35 1.13 0.88 1.48 
38 1.66 1.53 1.47 
41 0.96 1.12 0.60 
44 1.33 1.48 0.77 
48 0.65 0.84 0.83 
49 0.45 0.41 0.75 
 48 
        
Mean 1.45 1.49 1.51 
SEM 0.15 0.14 0.13 
    
2x Pre-Supp 0 24 
4 1.95 1.99 2.08 
6 2.18 2.10 1.96 
8 1.88 1.91 1.97 
10 1.95 1.94 1.97 
14 2.05 1.93 1.92 
16 2.02 2.03 1.83 
19 1.93 1.92 2.31 
22 1.74 1.49 1.77 
25 1.57 1.75 1.57 
28 1.25 1.72 1.58 
31 1.62 1.67 1.00 
34 1.17 0.80 1.63 
40 0.99 1.03 0.82 
43 0.86 0.73 1.04 
46 1.06 1.34 1.05 
        
Mean 1.62 1.62 1.63 





Placebo 0 2 24 48 73 96 
1 3.93 5.92 3.93 4.93 2.93 1.93 
2 2.93 3.93 5.92 1.93 3.93 3.93 
5 3.93 7.92 10.91 4.93 3.93 2.93 
7 2.29 5.34 6.36 4.32 1.27 1.27 
12 2.29 5.34 6.36 3.31 2.29 3.31 
18 1.80 7.82 6.10 1.80 3.52 4.38 
21 1.07 6.03 3.05 0.07 4.05 1.07 
24 1.07 5.04 3.05 3.05 0.07 3.05 
30 1.41 9.03 8.08 3.31 6.17 2.36 
33 2.36 6.17 8.08 4.27 4.27 2.36 
36 1.32 7.27 1.32 1.32 1.32 1.98 
39 2.64 5.94 2.64 2.64 2.64 1.32 
42 3.37 4.09 6.97 1.21 6.97 3.37 
45 3.37 6.97 3.37 2.65 1.93 3.37 
50 2.46 5.35 3.91 1.74 0.30 3.19 
              
Mean 2.41 6.14 5.34 2.76 3.04 2.65 
SEM 0.25 0.37 0.67 0.37 0.51 0.26 
       
1x 0 2 24 48 72 96 
3 3.93 4.93 4.93 3.93 3.93 2.93 
9 4.32 7.37 7.37 4.32 3.31 2.29 
11 2.29 5.34 5.34 3.31 1.27 4.32 
13 3.52 4.38 5.24 0.94 0.94 0.94 
17 1.80 4.38 2.66 1.80 1.80 0.94 
20 2.06 2.06 1.07 1.07 4.44 1.07 
26 1.07 4.05 0.07 0.07 5.04 2.06 
29 2.36 5.22 12.84 8.08 9.03 13.80 
32 1.41 8.08 1.41 1.41 1.41 2.36 
35 1.98 4.62 1.32 2.64 2.64 3.30 
38 2.64 3.96 15.20 2.64 3.96 2.64 
41 3.37 4.09 6.97 2.65 3.37 3.37 
44 4.09 7.69 3.37 4.81 3.37 1.93 
48 2.46 4.63 2.46 2.46 1.74 3.91 
49 3.91 4.63 1.74 1.02 1.74 1.02 
 50 
              
Mean 2.75 5.03 4.80 2.74 3.20 3.12 
SEM 0.27 0.41 1.13 0.52 0.53 0.81 
       
2x 0 2 24 48 72 96 
4 5.92 6.92 6.92 4.93 2.93 2.93 
6 5.92 4.93 7.92 3.93 0.93 4.93 
8 3.31 7.37 5.34 3.31 1.27 1.27 
10 4.32 3.31 6.36 1.27 6.36 3.31 
14 3.52 2.66 8.68 0.08 0.94 3.52 
16 3.52 7.82 4.38 1.80 2.66 0.94 
19 3.52 3.52 6.10 0.08 8.68 4.38 
22 3.05 3.05 2.06 4.05 2.06 2.06 
25 2.06 3.05 4.05 0.07 1.07 1.07 
28 2.36 4.27 6.17 7.13 6.17 5.22 
31 4.27 10.94 9.03 4.27 3.31 4.27 
34 2.64 8.59 6.61 5.94 5.28 1.32 
40 1.32 2.64 2.64 1.98 2.64 4.62 
43 3.37 2.65 4.81 2.65 2.65 1.93 
46 2.65 4.09 1.21 1.93 2.65 1.93 
              
Mean 3.45 5.05 5.48 2.89 3.31 2.91 




Interluekin-6 (percent increase of baseline) 
Placebo 0 2 24 48 72 96 
1 100.00 150.82 100.00 125.41 74.59 49.18 
2 100.00 134.07 202.20 65.93 134.07 134.07 
5 100.00 201.64 277.87 125.41 100.00 74.59 
7 100.00 233.13 277.51 188.75 55.62 55.62 
12 100.00 233.13 277.51 144.38 100.00 144.38 
18 100.00 435.32 339.51 100.00 195.81 243.71 
21 100.00 565.67 286.27 6.87 379.40 100.00 
24 100.00 472.53 286.27 286.27 6.87 286.27 
30 100.00 641.77 574.05 235.44 438.61 167.72 
33 100.00 261.51 342.26 180.75 180.75 100.00 
36 100.00 551.04 100.00 100.00 100.00 150.12 
39 100.00 225.14 100.00 100.00 100.00 49.94 
42 100.00 121.38 206.91 35.85 206.91 100.00 
45 100.00 206.91 100.00 78.62 57.23 100.00 
50 100.00 217.30 158.65 70.68 12.03 129.32 
              
Mean 100.00 310.09 241.93 122.96 142.79 125.66 
SEM 0.00 44.71 32.95 19.28 31.95 17.49 
       
1x 0 2 24 48 72 96 
3 100.00 125.41 125.41 100.00 100.00 74.59 
9 100.00 170.53 170.53 100.00 76.49 52.98 
11 100.00 233.13 233.13 144.38 55.62 188.75 
13 100.00 124.46 148.93 26.61 26.61 26.61 
17 100.00 243.71 147.90 100.00 100.00 52.10 
20 100.00 100.00 51.78 51.78 215.73 51.78 
26 100.00 379.40 6.87 6.87 472.53 193.13 
29 100.00 221.13 544.15 342.26 382.64 584.53 
32 100.00 574.05 100.00 100.00 100.00 167.72 
35 100.00 233.54 66.62 133.38 133.38 166.77 
38 100.00 150.06 575.55 100.00 150.06 100.00 
41 100.00 121.38 206.91 78.62 100.00 100.00 
44 100.00 188.08 82.38 117.62 82.38 47.15 
48 100.00 187.97 100.00 100.00 70.68 158.65 
49 100.00 118.48 44.55 26.06 44.55 26.06 
              
 52 
Mean 100.00 211.42 173.65 101.84 140.71 132.72 
SEM 0.00 31.81 43.48 20.04 32.58 35.78 
       
2x 0 2 24 48 72 96 
4 100.00 116.85 116.85 83.15 49.46 49.46 
6 100.00 83.15 133.70 66.30 15.76 83.15 
8 100.00 222.95 161.47 100.00 38.53 38.53 
10 100.00 76.49 147.02 29.47 147.02 76.49 
14 100.00 75.54 246.79 2.14 26.61 100.00 
16 100.00 222.32 124.46 51.07 75.54 26.61 
19 100.00 100.00 173.39 2.14 246.79 124.46 
22 100.00 100.00 67.47 132.53 67.47 67.47 
25 100.00 148.22 196.44 3.56 51.78 51.78 
28 100.00 180.75 261.51 301.89 261.51 221.13 
31 100.00 256.37 211.69 100.00 77.66 100.00 
34 100.00 325.26 250.17 225.14 200.12 49.94 
40 100.00 200.23 200.23 150.12 200.23 350.58 
43 100.00 78.62 142.77 78.62 78.62 57.23 
46 100.00 154.40 45.60 72.80 100.00 72.80 
              
Mean 100.00 156.08 165.30 93.26 109.14 97.98 
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